Behavioral: Withings Body+ scale ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 113 | 筋ジストロフィー | 1 |
113. 筋ジストロフィー
臨床試験数 : 622 / 薬物数 : 485 - (DrugBank : 99) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 168
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04999735 (ClinicalTrials.gov) | April 14, 2019 | 2/7/2019 | Digital Biotyping of FSHD Patients and Controls | An Exploratory, Non-interventional Study to Biotype Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Controls Using Digital Technologies | Muscular Dystrophy, Facioscapulohumeral | Behavioral: CHDR Monitoring Remotely (MORE);Behavioral: Withings Steel HR;Behavioral: Withings Body+ scale;Behavioral: Withings Blood Pressure Monitor | Centre for Human Drug Research, Netherlands | Facio Therapeutics | Completed | 16 Years | N/A | All | 58 | Netherlands |